Huiying Medical Upgrades Three Core Product Lines at CCR2019 to Build a Comprehensive Smart Imaging Ecosystem
With the rapid development of artificial intelligence (AI) technology applications, its value has permeated every industry. The impact of AI on the healthcare sector is particularly comprehensive.From research to clinical practice, the convergence of historical pain points with emerging market demand trends has formed the intrinsic driving force for industrial innovation., artificial intelligence technology will be deeply integrated into the healthcare industry at the foundational level of the medical ecosystem, as well as in medical information storage management and data mining for decision-making.
From November 14 to 16, 2019, the 26th National Congress of Radiology of the Chinese Medical Association (CCR2019) was held at the China National Convention Center in Beijing. The conference invited thousands of renowned experts and scholars from the radiology community both domestically and internationally to exchange insights, while numerous companies in the medical imaging sector gathered to showcase their AI innovations.
At the conference, we saw Huiyi Huiying, a leading enterprise in the imaging AI industry that focuses on imaging AI and has taken the lead in deploying full-chain solutions, once again showcased its full range of product innovation achievements to the world.
At the largest booth in the imaging AI industry at this year's CCR,Huiyi Huiying applies artificial intelligence to scenarios involving imaging research, imaging screening and diagnosis, and patient usage. By integrating its full product line into three scenario-based demonstration zones, the company provided attending experts and leaders with a novel experience of its comprehensive smart imaging solutions, presenting a more holistic and clear portrait of AI in medical imaging.
Professor Jin Zhengyu, Chairman of the Chinese Society of Radiology (CSR); Professor Chen Min, Vice-Chairman; Professor Feng Xiaoyuan, Honorary Chairman; Professor Fu Haihong, Chairman of the Chinese Society of Imaging Technology; Professor Hong Nan, Secretary-General of the Society; and Professor Zhou Chunwu, Chairman of the Oncologic Imaging Committee, along with other renowned experts and leaders in the field of radiology, visited the Huiyi Huiying booth and spoke highly of Huiyi Huiying’s comprehensive smart imaging solutions.
Representative Experts in Attendance Visit the Booth to Experience Huiyi Huiying’s Full Line of AI-Powered Research, Diagnostic and Therapeutic, and Imaging Cloud Products
In medical imaging research scenarios, the Huiyi Huiying Big Data and Artificial Intelligence Research Platform has effectively addressed challenges such as time-consuming and labor-intensive data integration, high barriers to entry for research, difficulties in implementing multi-center studies, and obstacles to the clinical translation of research findings.
Driven by imaging data dimensions, the platform integrates deep learning and radiomics analysis methods. It incorporates multi-modal imaging data along with non-imaging data—including genomic, proteomic, pathological, and follow-up data—to enable effective management and mine latent features within imaging data, thereby unlocking its value.. Assist physicians in efficiently conducting high-quality scientific research, publishing high-impact papers, enhancing the hospital’s research capabilities, and strengthening disciplinary expertise.
Huiyi Huiying’s Big Data and AI Research Platform is the imaging big data research product with the largest user base and the broadest range of research topics in China, and it is also widely used in countries such as the United States and Japan.
To date, it has provided one-stop intelligent scientific research services to nearly 30,000 physicians both in China and abroad, improving research efficiency by 80%. It has successfully secured over 20 research grants, including those from the National Natural Science Foundation of China. The acceptance rate for high-quality papers has reached as high as 80%, with achievements presented at top international radiology conferences such as SCI, RSNA, and ISMRM.Currently, the Huiyi Huiying Research Platform is fully open for trial use, facilitating the translation of research value.。
In imaging screening and diagnostic scenarios, Huiyi Huiying globally launched its comprehensive AI-powered multi-disease imaging solution at the conference.Centered on “multi-disease, personalized, and structured” approaches, build an end-to-end AI imaging solution.First effective integration of AI-assisted diagnostic products with an AI-structured reporting system.
By leveraging deep learning algorithms to effectively capture decades of expert experience and knowledge, this approach helps mitigate diagnostic accuracy disparities among radiologists due to varying levels of experience, reduces misdiagnoses and missed diagnoses caused by fatigue during image interpretation, improves diagnostic accuracy, enhances work efficiency, and alleviates the shortage of radiologists. Meanwhile, it significantly improves the efficiency and quality of imaging report writing, enabling standardized and unified imaging reports.To provide effective data for further data mining and research, accelerate the construction of knowledge graphs, further enhance the level of hospital informatization and disciplinary influence, and respond to national requirements for graded informatization.
It now supports multiple conditions, including DR-based tuberculosis screening, DR-based detection of extremity bone fractures, CT-based lung nodule screening, prostate cancer detection, mammography-based breast cancer screening, and assisted diagnosis and treatment for aortic dissection and abdominal aortic aneurysm. It covers various application scenarios such as primary care screening, health check-up screening, outpatient diagnosis, clinical treatment, and postoperative follow-up, thereby accelerating the development of smart hospitals.Benefiting hospitals, physicians, and patients alike, it maximizes imaging quality and clinical outcomes.
In patient-use scenarios, Huiyi Huiying’s Intelligent Imaging Cloud aligns with the trends of next-generation healthcare consumer behavior and the patient-centered transformation of medical services. Leveraging its independently developed technological foundation across its full product portfolio, it providesthe only imaging cloud platform in China with seamless AI integration.
Leveraging cloud computing, big data, and artificial intelligence technologies, and adopting a microservices architecture as the technical pathway with a data middle platform as the core of big data governance, we deliver business functionalities such as cloud-based image storage and backup, cloud RIS/PACS, mobile image viewing, AI-assisted diagnosis, remote imaging consultation, and digital intelligent film. This provides professional and intelligent medical imaging cloud services for smart hospitals, urban medical groups, county-level medical communities, specialized alliances, telemedicine collaborations, and regional imaging cloud initiatives.
The exhibition also showcased the latest upgrade to digital smart film, the component of the Smart Imaging Cloud most closely linked to patients.Digital Smart Film became the first in the industry to launch multiple payment models, including patient-paid options., through simple configuration on the management platform, hospitals and patients can achieve pay-per-use billing based on time and demand, thereby giving rise to more flexible and diverse business models. This will undoubtedly open up a new landscape for the implementation of digital intelligent film. Secondly, the digital intelligent film system leads the industry by adding support for ultrasound imaging, further driving industry development.
From lowering barriers to smart research and accelerating the monetization of data value, to enhancing diagnostic efficiency in clinical settings and supporting precise diagnosis and treatment decisions; from accumulating high-quality data through intelligent structured reporting, to achieving interconnectivity via smart imaging clouds; from facilitating tiered diagnosis and treatment and the development of smart hospitals, to delivering inclusive, high-quality medical services centered on patients...The Value Loop of Imaging Data Is Beginning to Take Shape with AI Empowerment, the seeds sown at the inception of Huiyi Huiying began to sprout.
The integration of AI and medical imaging is not merely about answering specific questions; rather, the true path to substantial progress in imaging AI lies in leveraging AI to support a full-chain closed loop in imaging, creating greater and more far-reaching value through problem-solving, and fostering a thriving ecosystem for imaging AI. Huiyi Huiying will remain true to its original aspiration, forge ahead with determination, continue to refine the comprehensive smart imaging ecosystem, nurture the robust growth of big data in imaging healthcare, and unleash greater power across the value chain of imaging data.